TWD 10.75
(0.47%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -169.55 Million TWD | -124.09% |
2022 | -76.12 Million TWD | -400.49% |
2021 | -15.21 Million TWD | 84.86% |
2020 | -100.48 Million TWD | 11.81% |
2019 | -113.94 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -53.19 Thousand TWD | 0.0% |
2024 Q1 | -53.19 Thousand TWD | 15.53% |
2023 Q3 | -62.97 Thousand TWD | -188.78% |
2023 FY | -170.59 Million TWD | -124.09% |
2023 Q2 | -21.8 Thousand TWD | 0.0% |
2023 Q1 | -21.8 Thousand TWD | -2.61% |
2023 Q4 | -62.97 Thousand TWD | 0.0% |
2022 FY | -76.12 Million TWD | -400.49% |
2022 Q3 | -21.25 Thousand TWD | 0.0% |
2022 Q4 | -21.25 Thousand TWD | 0.0% |
2021 FY | -15.21 Million TWD | 84.86% |
2020 FY | -100.48 Million TWD | 11.81% |
2019 FY | -113.94 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 160.158% |
Level Biotechnology Inc. | 67.55 Million TWD | 351.001% |
Sagittarius Life Science Corp | -64.37 Million TWD | -163.384% |
NeoCore Technology Co., Ltd. | -84.94 Million TWD | -99.609% |
GeneReach Biotechnology Corp. | -229.28 Million TWD | 26.05% |
Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -99.492% |
Visgeneer Inc. | -21.15 Million TWD | -701.342% |
Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 118.949% |
G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 310.148% |
Neith Corporation | -48.85 Million TWD | -247.067% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -2465.144% |
Enimmune corporation | -243.47 Million TWD | 30.36% |
TaiRx, Inc. | -214.69 Million TWD | 21.025% |
EirGenix Inc. | -1.03 Billion TWD | 83.57% |
BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 367.713% |
Sunny Pharmtech Inc. | -72.09 Million TWD | -135.181% |
Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -81.662% |
BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 3.957% |
Feng Chi Biotech Corp. | 24.16 Million TWD | 801.747% |
Lukas Biomedical Inc. | -43.56 Million TWD | -289.247% |
RBC Bioscience Corporation | 14.53 Million TWD | 1266.215% |
BiOptic Inc. | 44.05 Million TWD | 484.891% |
Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -198.782% |
Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -170.498% |
Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -157.606% |
Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 150.753% |
Mycenax Biotech Inc. | -602.1 Million TWD | 71.839% |
Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 86.031% |
Bio Preventive Medicine Corp. | -70.58 Million TWD | -140.226% |
TaiMed Biologics Inc. | -166.23 Million TWD | -2.0% |
GlycoNex Incorporation | -259.86 Million TWD | 34.752% |
Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -7425.788% |
SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -272.634% |
Lin BioScience, Inc. | -1.09 Billion TWD | 84.541% |
BRIM Biotechnology, Inc. | -694.12 Million TWD | 75.573% |
VBI | -16.13 Million TWD | -951.054% |
CHO Pharma, Inc. | -268.99 Million TWD | 36.968% |
NaviFUS Corp. | -76.42 Million TWD | -121.856% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -80.465% |
Sinew Pharma Inc. | -186.25 Million TWD | 8.965% |
Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -150.463% |
Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 206.094% |
Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 54.86% |
AP Biosciences Inc | -347.47 Million TWD | 51.204% |
Medigen Biotechnology Corp. | -1.23 Billion TWD | 86.25% |
3D Global Biotech Inc. | -62.85 Million TWD | -169.766% |
Pharmosa Biopharm Inc. | -2.82 Million TWD | -5904.108% |
Intech Biopharm Corporation | -304.39 Million TWD | 44.298% |
Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 84.538% |
Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -308.746% |
Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 150.204% |
TCI GENE Inc. | 10.04 Million TWD | 1787.292% |
MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -33.239% |
Senhwa Biosciences, Inc. | -311.11 Million TWD | 45.5% |
Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 20.098% |
NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 5037.566% |
PharmaEngine, Inc. | 277.18 Million TWD | 161.171% |
Savior Lifetec Corporation | -2.42 Million TWD | -6906.446% |
TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 2.944% |
OBI Pharma, Inc. | -2.08 Billion TWD | 91.886% |
Meribank Biotech Co., Ltd | -123.15 Million TWD | -37.678% |
Acepodia, Inc. | -435.97 Million TWD | 61.109% |
Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 65.252% |